PTCT · Ptc Therapeutics, Inc. · Debt
$62.92
+1.39 (+2.26%)
At close · Oct 20
View the 10-K filed Feb 19, 2026
Return incl. dividend (before tax)
Customer concentration
— top 4 customers 10% of revenue
4 customers — 10% of revenue (2025)
“During 2025, four of our distributors each accounted for over 10% of our net product sales.”
Market Cap
$5.14B
Shares
83.46M
Volume · Oct 20
965.8K
Avg daily vol (3M)
1.12M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current finance lease liabilities | 2026-06-30 | USD 6,000,000 | 10-Q filed 2026-07-30 |
| Current operating lease liabilities | 2026-06-30 | USD 11,965,000 | 10-Q filed 2026-07-30 |
| Current portion of long-term debt | 2026-06-30 | USD 55,451,000 | 10-Q filed 2026-07-30 |
| Noncurrent debt carrying amount | 2026-06-30 | USD 535,519,000 | 10-Q filed 2026-07-30 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 87,533,000 | 10-Q filed 2026-07-30 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1070081
CUSIP
69366J200
13F (30d)
37 filings
36 filers
Visit website
Investor relations